Bristol Myer Stock Gets a Bump on FDA Approval for Schizophrenia Drug: Is it Time to Buy BMY?
Late last week Bristol Myers Squibb (BMY) got a nice 8% boost after sharing news that it gained approval from the Food and Drug Administration (FDA) for its schizophrenia drug. The stock has cooled off since and is up just shy of 4% over the past week, but it has been on a serious tear over the past few [...]
Weekly Market Recap: Major Indices Manage Gains Amid Economic Data Releases
Monday: The Major Indices started the week in positive territory with investors keeping an eye on the upcoming Personal Consumption Expenditures report. The Dow rose 0.2%, the S&P 500 gained 0.3%, and the Nasdaq added 0.1%. Tuesday: China's new stimulus plan helped boost sentiment despite lower-than-expected housing data, leading to another day of gains. The Dow increased 0.2%, the [...]
Investors’ Inspiration
Written by: Angela Akers In last week’s “Special Presentation,” Mr. Steve Chappell discussed and demonstrated the efficacy and effectiveness of the VectorVest RealTime Derby. The Derby analyzes, sorts, ranks and graphs the second-by-second performance of 169 portfolios. It tracks each portfolio’s performance from the current day’s opening bell and displays the results from the previous day’s close or the [...]
Accenture Gains Nearly 6% on Rising Demand for AI Solutions: 2 Other Reasons It’s Time to Buy ACN
Shares of Accenture (ACN) are up just under 6% in the past week amidst hype for the company’s AI-powered performance in the fourth quarter. The business management consultant posted adjusted earnings per share of $2.79, which matched the analyst consensus. Revenue of $16.41 billion was a 2.6% improvement year over year and ahead of the estimate for just $16.39 [...]
Snowflake is Sinking After Announcing $2 Billion Debt Plan: Should Investors Be Concerned?
Shares of Snowflake Inc. (SNOW) are down roughly 2% Thursday morning, making it a 6% loss over the past month. The latest bit of downward pressure can be attributed to the company’s announcement that it will be raising $2 billion in debt. The plan involves two separate $1 billion Senior Convertible Notes, one of which will be due in [...]
GM Takes a Dip After Former Bull Downgrades the Stock: 3 Things Investors Need to Know About GM
Shares of General Motors Co. (GM) are down more than 5% so far Wednesday morning, making for a 7% loss over the past month. This comes on the heels of a once-bullish analyst changing his stance on the stock, downgrading it from the equivalent of buy to hold. Daniel Roeska with Bernstein moved his price target from $54.50 to [...]